A groundbreaking genetic study of more than 15,000 Latin American individuals has found that the biological basis of autism spectrum disorder (ASD) is fundamentally the same across all populations, regardless of ancestral background. Researchers identified 35 genes strongly associated with autism, with findings that closely mirror discoveries from studies of European populations, suggesting that autism genetics transcends racial and ethnic boundaries .

Why Does Genetic Research on Diverse Populations Matter?

For decades, genetic studies of autism have heavily focused on people of European ancestry, creating a significant blind spot in our understanding of the condition. The Genomics of Autism in Latin American Ancestries (GALA) Consortium was established to address this gap. The consortium's new research, which included 4,717 participants with an autism diagnosis, represents the largest sequencing study of autism in Latin American individuals to date .

This inclusive approach matters because it ensures that genetic testing and future treatments can be developed and validated for all populations, not just those of European descent. When research excludes certain groups, people from those backgrounds may not benefit equally from advances in genetic medicine.

What Did the Study Find About Autism Genes?

The research identified 35 genome-wide significant autism-associated genes with high statistical certainty. What's particularly striking is the substantial overlap between genes found in the Latin American cohort and those previously identified in European populations. This consistency across different ancestral groups provides strong evidence that the fundamental genetic architecture of autism is universal .

Among the genes identified were both newly emerging candidates and well-established autism genes. The emerging genes included MARK2, YWHAG, PACS1, RERE, SPEN, GSE1, GLS, TNPO3, and ANKRD17, while the study also confirmed the role of previously known autism-associated genes. The researchers noted that highly constrained genes, which are particularly sensitive to genetic mutations, showed consistent signals across all populations studied .

How Can This Research Improve Autism Diagnosis and Care?

• Genetic Testing Access: The findings support the utility of genetic testing approaches for deleterious variants in individuals from diverse backgrounds, meaning people of Latin American ancestry can now benefit from genetic screening that was previously validated only in European populations.
• Personalized Medicine Development: Understanding that autism genetics is consistent across populations allows researchers to develop treatments and interventions that can be applied more broadly, rather than creating population-specific approaches.
• Reduced Health Disparities: Inclusive genetic research helps ensure that advances in understanding autism biology translate into equitable improvements in diagnosis and care for all communities, not just those historically overrepresented in medical research.

The study's conclusion is clear and important: the biology of autism is consistent across populations, with no detectable influence of ancestry . This finding challenges any notion that autism manifests differently based on genetic background and reinforces that the condition has universal biological underpinnings.

The GALA Consortium's work demonstrates the ongoing need for more inclusive genetic research. When large-scale studies exclude or underrepresent certain populations, it creates gaps in medical knowledge that can perpetuate health disparities. By including more than 15,000 individuals from Latin American ancestries, this research ensures that future genetic discoveries and clinical applications will be relevant and applicable to a broader segment of the global population.

For families seeking genetic testing or counseling related to autism, these findings suggest that the same genetic principles and testing approaches used in European populations can be reliably applied to individuals of Latin American ancestry. This represents a significant step forward in making precision medicine truly inclusive and equitable across all communities.